Literature DB >> 26701217

Diabetes: Lixisenatide does not increase rates of CVD events.

Karina Huynh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26701217     DOI: 10.1038/nrcardio.2015.199

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

Authors:  Marc A Pfeffer; Brian Claggett; Rafael Diaz; Kenneth Dickstein; Hertzel C Gerstein; Lars V Køber; Francesca C Lawson; Lin Ping; Xiaodan Wei; Eldrin F Lewis; Aldo P Maggioni; John J V McMurray; Jeffrey L Probstfield; Matthew C Riddle; Scott D Solomon; Jean-Claude Tardif
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.